(Q79331609)
Statements
Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin (English)
Przemyslaw J Kotyla
Bogna Sliwinska-Kotyla
1 November 2006
2361-3; author reply 2363